A Pre-Clinical Validation Plan to Evaluate Analytical Sensitivities of Molecular Diagnostics Such as BD MAX MDR-TB, Xpert MTB/Rif Ultra and FluoroType MTB

PLoS ONE - United States
doi 10.1371/journal.pone.0227215

Related search